HLA-A *3303* and *3301 predispose patients to persistent hepatitis B infection

J Gastrointestin Liver Dis. 2009 Mar;18(1):117-8.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Gene Frequency
  • Genetic Predisposition to Disease
  • HLA-A Antigens / genetics*
  • HLA-DR Antigens / genetics
  • HLA-DRB1 Chains
  • Hepatitis B, Chronic / drug therapy
  • Hepatitis B, Chronic / genetics*
  • Hepatitis B, Chronic / immunology
  • Humans
  • Phenotype
  • Polymorphism, Genetic
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Antiviral Agents
  • HLA-A Antigens
  • HLA-A*33 antigen
  • HLA-DR Antigens
  • HLA-DRB1 Chains